2.23
price up icon0.45%   0.010
after-market 시간 외 거래: 2.23
loading
전일 마감가:
$2.22
열려 있는:
$2.24
하루 거래량:
58,883
Relative Volume:
0.82
시가총액:
$91.44M
수익:
$2.70M
순이익/손실:
$5.53M
주가수익비율:
20.27
EPS:
0.11
순현금흐름:
$-10.55M
1주 성능:
+1.36%
1개월 성능:
+7.21%
6개월 성능:
-3.04%
1년 성능:
-3.46%
1일 변동 폭
Value
$2.1698
$2.2515
1주일 범위
Value
$2.13
$2.26
52주 변동 폭
Value
$1.82
$3.09

Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile

Name
명칭
Oramed Pharmaceuticals Inc
Name
전화
646-844-1164
Name
주소
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Name
직원
13
Name
트위터
@OramedPharma
Name
다음 수익 날짜
2025-08-19
Name
최신 SEC 제출 서류
Name
ORMP's Discussions on Twitter

ORMP을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
ORMP
Oramed Pharmaceuticals Inc
2.23 91.03M 2.70M 5.53M -10.55M 0.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.12 101.77B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
573.38 60.12B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
452.00 59.45B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
750.78 44.90B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
341.80 35.07B 3.81B -644.79M -669.77M -6.24

Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2023-01-12 다운그레이드 Canaccord Genuity Buy → Hold
2022-02-18 개시 Cantor Fitzgerald Overweight
2021-04-20 개시 Canaccord Genuity Buy
2021-02-09 개시 National Securities Buy
2020-12-03 개시 Alliance Global Partners Buy
2020-03-11 개시 Aegis Capital Buy
2019-09-11 개시 Ladenburg Thalmann Buy
2017-12-11 재개 B. Riley FBR, Inc. Buy
2016-05-26 재확인 FBR Capital Outperform
2015-12-01 재확인 H.C. Wainwright Buy
2015-11-19 개시 FBR Capital Outperform
2015-04-13 재개 MLV & Co Buy
2014-01-30 재확인 Aegis Capital Buy
2014-01-08 재확인 Aegis Capital Buy
2014-01-08 개시 MLV & Co Buy
2013-12-03 개시 Aegis Capital Buy
모두보기

Oramed Pharmaceuticals Inc 주식(ORMP)의 최신 뉴스

pulisher
03:14 AM

Does Oramed Pharmaceuticals Inc. fit your quant trading modelJuly 2025 Intraday Action & High Yield Stock Recommendations - Newser

03:14 AM
pulisher
09:10 AM

Applying big data sentiment scoring on Oramed Pharmaceuticals Inc.Quarterly Earnings Report & Risk Managed Investment Strategies - Newser

09:10 AM
pulisher
05:25 AM

Is Oramed Pharmaceuticals Inc. a top pick in the sectorPortfolio Value Report & Verified Momentum Stock Watchlist - خودرو بانک

05:25 AM
pulisher
04:49 AM

Can Oramed Pharmaceuticals Inc. lead its sector in growth2025 Dividend Review & Intraday High Probability Setup Alerts - خودرو بانک

04:49 AM
pulisher
02:08 AM

Will Oramed Pharmaceuticals Inc. outperform during market ralliesQuarterly Risk Review & Real-Time Volume Analysis Alerts - خودرو بانک

02:08 AM
pulisher
Sep 05, 2025

Sentiment analysis tools applied to Oramed Pharmaceuticals Inc.Jobs Report & Weekly Consistent Profit Watchlists - Newser

Sep 05, 2025
pulisher
Sep 05, 2025

Is Oramed Pharmaceuticals Inc. forming a double bottomMarket Volume Summary & Verified Momentum Watchlists - خودرو بانک

Sep 05, 2025
pulisher
Sep 05, 2025

Using Bollinger Bands to evaluate Oramed Pharmaceuticals Inc.Weekly Trend Recap & High Return Trade Opportunity Guides - Newser

Sep 05, 2025
pulisher
Sep 04, 2025

What to expect from Oramed Pharmaceuticals Inc. in the next 30 days2025 Dividend Review & Free Expert Verified Stock Movement Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Is Oramed Pharmaceuticals Inc. forming a reversal patternEarnings Growth Summary & Community Verified Watchlist Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Chart based analysis of Oramed Pharmaceuticals Inc. trends2025 Volatility Report & Fast Entry High Yield Tips - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How to use Fibonacci retracement on Oramed Pharmaceuticals Inc.Quarterly Growth Report & AI Powered Market Entry Ideas - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

How cyclical is Oramed Pharmaceuticals Inc.’s revenue streamWeekly Loss Report & Stock Portfolio Risk Management - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

Statistical indicators supporting Oramed Pharmaceuticals Inc.’s strength2025 Price Action Summary & Free Real-Time Volume Trigger Notifications - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Can Oramed Pharmaceuticals Inc. recover in the next quarterJuly 2025 Macro Moves & Entry and Exit Point Strategies - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Oramed Pharmaceuticals Inc. stock retracement – recovery analysisJuly 2025 Setups & Technical Pattern Based Buy Signals - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

What to do if you’re stuck in Oramed Pharmaceuticals Inc.Dip Buying & Intraday High Probability Setup Alerts - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Market Outlook: How cyclical is Oramed Pharmaceuticals Inc.’s revenue streamJuly 2025 Trends & Weekly Top Performers Watchlists - خودرو بانک

Sep 04, 2025
pulisher
Sep 04, 2025

What MACD and RSI say about Oramed Pharmaceuticals Inc.Weekly Trade Report & Weekly Breakout Opportunity Watchlist - Newser

Sep 04, 2025
pulisher
Sep 04, 2025

Is a relief rally coming for Oramed Pharmaceuticals Inc. holdersTake Profit & Daily Growth Stock Investment Tips - Newser

Sep 04, 2025
pulisher
Sep 03, 2025

Is this a good reentry point in Oramed Pharmaceuticals Inc.Market Rally & Risk Managed Investment Strategies - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Intraday pattern recognizer results for Oramed Pharmaceuticals Inc.2025 Biggest Moves & Fast Moving Market Watchlists - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Evaluating Oramed Pharmaceuticals Inc. with trendline analysis2025 Price Action Summary & Breakout Confirmation Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Will Oramed Pharmaceuticals Inc. rebound enough to break evenPortfolio Risk Report & Real-Time Stock Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Historical volatility pattern of Oramed Pharmaceuticals Inc. visualizedEarnings Growth Summary & Free Community Supported Trade Ideas - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Tick level data insight on Oramed Pharmaceuticals Inc. volatility - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Oramed Pharmaceuticals Inc. still worth holding after the dipEarnings Risk Report & AI Enhanced Trading Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Can Oramed Pharmaceuticals Inc. sustain earnings growthEarnings Overview Report & Weekly Top Gainers Alerts - خودرو بانک

Sep 03, 2025
pulisher
Sep 02, 2025

How sensitive is Oramed Pharmaceuticals Inc. to inflationJuly 2025 EndofMonth & Verified Entry Point Signals - خودرو بانک

Sep 02, 2025
pulisher
Sep 02, 2025

Building trade automation scripts for Oramed Pharmaceuticals Inc.July 2025 Decliners & Real-Time Market Sentiment Alerts - Newser

Sep 02, 2025
pulisher
Sep 01, 2025

Is Oramed Pharmaceuticals Inc. currently under institutional pressureWeekly Profit Analysis & Daily Profit Maximizing Tips - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Does Oramed Pharmaceuticals Inc. stock reflect fundamentals2025 Earnings Impact & Real-Time Chart Pattern Alerts - خودرو بانک

Sep 01, 2025
pulisher
Sep 01, 2025

Should you hold or exit Oramed Pharmaceuticals Inc. nowPortfolio Profit Report & Smart Allocation Stock Tips - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

What to do if you’re stuck in Oramed Pharmaceuticals IncTake Profit & Expert Curated Trade Setup Alerts - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Can machine learning forecast Oramed Pharmaceuticals Inc. recovery2025 Earnings Impact & Weekly Market Pulse Updates - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Can volume confirm reversal in Oramed Pharmaceuticals Inc.Weekly Trade Report & AI Powered Buy/Sell Recommendations - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will Volume Confirm Reversal in Oramed Pharmaceuticals Inc. getLinesFromResByArray error: size == 0 - newsyoung.net

Aug 31, 2025

Oramed Pharmaceuticals Inc (ORMP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$86.64
price up icon 1.40%
$27.54
price up icon 0.58%
$25.98
price up icon 9.16%
$112.46
price up icon 8.66%
$145.10
price up icon 1.80%
biotechnology ONC
$341.80
price up icon 7.24%
자본화:     |  볼륨(24시간):